Evert B. Schimmelpennink, President, CEO and Secretary at LENZ Therapeutics, Inc. (LENZ), bought 56,178 shares at $8.95 ($503K) on 2026-03-27, disclosed to the SEC on 2026-03-30.
CEO Evert B. Schimmelpennink purchased 28,089 shares at $8.95, marking the largest purchase of his career, as the stock has crashed 48.57% over the last 90 days. This aggressive buyback comes while the shares trade near the 52-week low of $8.25, suggesting conviction in the biotech's turnaround potential.
The stock is currently trading at $8.29, down 48.57% over the last 90 days and just 0.48% above its 52-week low of $8.25.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.95 | 28,089 | $251K | 50.0% |
| 2 | $8.95 | 28,089 | $251K | 50.0% |
| Total | $8.95 avg | 56,178 | $503K | 100% |